You've just added:

Home / News

Articles

February 10, 2023

Potential Therapeutic Target for Blood Cancers Discovered

Investigators discovered that a specific complex drives cell proliferation in different forms of blood cancers called mutated myeloproliferative neoplasms (MPNs), suggesting the complex could serve as an ideal therapeutic target for blood cancer. Continue Reading

February 08, 2023

Single Drug Injection Wards off COVID-19 Hospitalizations, in Stanford Medicine-Led Trial

In an international, multicenter, pivotal Phase 3 trial, a single under-the-skin injection of a biological drug given to patients within seven days of the onset of COVID-19 symptoms cut the likelihood they needed to be hospitalized in half. Continue Reading

November 22, 2022

ASU Researchers Developing Pioneering Drug to Treat Alzheimer's Disease in Down Syndrome Patients

Travis Dunckley, PhD, University of Arizona, 2016 ADDF-Harrington Scholar and team have developed a candidate drug they hope may successfully block the development or advancement of Alzheimer’s disease in Down syndrome patients. Continue Reading

October 19, 2022

PIC Closes $35M Series A to Advance Novel Breast Cancer Therapeutic

PIC Therapeutics has closed a $35 million Series A financing round centered around the advancement of its lead asset, a novel therapeutic for advanced metastatic breast cancer. Continue Reading

August 18, 2022

Harrington Scholar Developing a Universal Therapeutic that can Prevent and Treat All Strains of Influenza A

Harrington Scholar developing a universal treatment to prevent and treat influenza A. Continue Reading

August 15, 2022

Novel Oral SIK Inhibitors for Musculoskeletal Diseases Licensed to Radius Health

Licensing IP for SIK Inhibitors to Radius Health Continue Reading

August 09, 2022

A Prescription for Exercise: Scientists Want to Help You Find the Best Workout for Your Brain

Development of an exercise wearable to help personalize exercise and minimize the risks of dementia. Continue Reading

February 05, 2022

Chiesi Enters Agreement with Allinaire Therapeutic, LLC

Chiesi Acquires Pioneering Therapeutic Monoclonal Antibodies Portfolio Against EMAP II as Potential Treatment for PAH Continue Reading

January 24, 2022

Linda and Les Vinney Scholar Program to Support New Treatments for Alzheimer’s Disease

Linda and Les Vinney committed $1.25 million to establish the Linda and Les Vinney Scholar Program at Harrington Discovery Institute's Center for Brain Health Medicine, which will support new treatments for patients living with Alzheimer's disease. The gift also creates the Linda and Les Vinney Acceleration Awards, which will... Continue Reading

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.